Michael J. Debiasi serves as Executive at RVL Pharmaceuticals plc, where they oversee executive responsibilities. Since joining the company, Michael J. Debiasi has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 5, 2023 involved receiving (via award) 40,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 5, 2023 | RVLP | $0 | Award | 40,000 | $N/A | Discretionary |
Michael J. Debiasi currently holds 40,000 shares of RVL Pharmaceuticals plc (RVLP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Debiasi has been a net neutral trader of RVLP stock. They have purchased $0 and sold $0 worth of shares.
Michael J. Debiasi's most recent insider trade was on Jul 5, 2023, when they sold 40,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted